ベータグルカンの北米市場

Inkwood Researchが発行した調査報告書(INKW807297)
◆英語タイトル:NORTH AMERICA BETA GLUCAN MARKET FORECAST 2018-2026
◆商品コード:INKW807297
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2018年5月14日
◆ページ数:94
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:北米、アメリカ
◆産業分野:CONSUMER GOODS & SERVICES, FOOD AND BEVERAGES
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD2,000 ⇒換算¥226,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

KEY FINDINGSThe North America beta glucan market is expected to progress at a 7.70% CAGR during the forecast period of 2018-2026. The unexploited beta glucan applications in cosmetic and medicine sector are expected to present this market with potential growth opportunities.
MARKET INSIGHTS
The pharmaceutical industry is an important end-user in the North American beta-glucan market. Other key end-users in this market include animal feed, personal care, and food and beverages industry. In 2017, the US market accounted for the highest share in the North America beta-glucan market. It was followed by the Canadian beta-glucan market, which is expected to progress at a CAGR of xx%. The country’s growing diabetic population and increasing number of ongoing clinical trials are boosting its market growth.
COMPETITIVE INSIGHTS
Pharmacon Asa, Frutarom, Specialty Biotech Ltd, Alltech Biotechnology, Milliporesigma (Merck), Tate & Lyle Plc, Lesaffre Human Care, Cargill Inc, Super Beta Glucan, Kemin Industries and Kerry Group Plc are few of the established market companies in this region.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. UNITED STATES TO WITNESS ROBUST GROWTH DURING THE FORECAST PERIOD
3.2.2. PHARMACEUTICAL- MAJOR MARKET BY END-USER
3.2.3. SOLUBLE BETA GLUCAN HELD MAJOR CHUNK OF THE MARKET BY CATEGORY
3.2.4. CEREALS TO OFFER LUCRATIVE OPPORTUNITIES
4. MARKET DYNAMICS
4.1. MARKET DEFINITION
4.2. DRIVERS
4.2.1. GROWING HEALTH CONCERN AMONG CONSUMERS AND INCREASING HEALTH EXPENDITURE
4.2.2. GROWING APPLICATIONS OF BETA-GLUCAN IN THE FOOD INDUSTRY
4.2.3. DECREASING PRICES OF MAJOR RAW MATERIAL SOURCES
4.3. RESTRAINTS
4.3.1. VARIOUS SIDE EFFECTS OF CONSUMING BETA GLUCAN
4.3.2. INCONSISTENCY IN REGULATORY NORMS
4.4. OPPORTUNITIES
4.4.1. UNEXPLOITED BETA GLUCAN APPLICATIONS IN COSMETIC AND MEDICINE SECTOR
4.5. CHALLENGES
4.5.1. INCREASE IN COST OF BETA-GLUCAN EXTRACTION PROCESS
5. MARKET BY SOURCE
5.1. BACTERIA
5.2. FUNGUS
5.3. YEAST
5.4. CEREAL
5.5. ALGAE
6. MARKET BY END-USERS
6.1. FOOD AND BEVERAGES
6.2. PERSONAL CARE
6.3. PHARMACEUTICALS
6.4. ANIMAL FEED
7. MARKET BY CATEGORY
7.1. INSOLUBLE BETA GLUCAN
7.2. SOLUBLE BETA GLUCAN
8. KEY ANALYTICS
8.1. PORTER’S 5 FORCE MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE PRODUCTS
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER OF SUPPLIERS
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. KEY BUYING CRITERIA
8.2.1. COST
8.2.2. NUTRITIONAL CONTENT
8.2.3. SOURCE
8.2.4. APPLICATIONS
8.3. VALUE CHAIN ANALYSIS
8.3.1. RAW MATERIAL SUPPLIERS
8.3.2. MANUFACTURING
8.3.3. DISTRIBUTORS/RETAILERS
8.3.4. END-USERS
8.4. REGULATORY FRAMEWORK
8.5. KEY TRENDS
8.5.1. RISING PREVALENCE OF DIABETES
8.5.2. INVESTMENTS IN BETA GLUCAN
8.6. INVESTMENT OUTLOOK
8.6.1. END-USERS OUTLOOK
8.7. VENDOR LANDSCAPE
8.8. OPPORTUNITY MATRIX
9. GEOGRAPHICAL ANALYSIS
9.1. US
9.2. CANADA
10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.1.1. CARGILL INC (US)
10.1.2. TATE & LYLE (UK)
10.1.3. KERRY GROUP PLC (ISRAEL)
10.1.4. OHLY (GERMANY)
10.1.5. KONINKLIJKE DSM N.V. (NETHERLANDS)
10.2. COMPANY PROFILES
10.2.1. ALLTECH BIOTECHNOLOGY
10.2.1.1. OVERVIEW
10.2.1.2. PRODUCT PORTFOLIO
10.2.1.3. SCOT ANALYSIS
10.2.1.4. STRATEGIC ANALYSIS
10.2.2. CARGILL INC
10.2.2.1. OVERVIEW
10.2.2.2. PRODUCT PORTFOLIO
10.2.2.3. SCOT ANALYSIS
10.2.2.4. STRATEGIC ANALYSIS
10.2.3. CHR. HANSEN A/S
10.2.3.1. OVERVIEW
10.2.3.2. PRODUCT PORTFOLIO
10.2.3.3. SCOT ANALYSIS
10.2.3.4. STRATEGIC ANALYSIS
10.2.4. GARUDA INTERNATIONAL INC
10.2.4.1. OVERVIEW
10.2.4.2. PRODUCT PORTFOLIO
10.2.4.3. SCOT ANALYSIS
10.2.4.4. STRATEGIC ANALYSIS
10.2.5. KEMIN INDUSTRIES
10.2.5.1. OVERVIEW
10.2.5.2. PRODUCT PORTFOLIO
10.2.5.3. STRATEGIC INITIATIVES
10.2.5.4. SCOT ANALYSIS
10.2.5.5. STRATEGIC ANALYSIS
10.2.6. SPECIALTY BIOTECH LTD
10.2.6.1. OVERVIEW
10.2.6.2. PRODUCT PORTFOLIO
10.2.6.3. SCOT ANALYSIS
10.2.6.4. STRATEGIC ANALYSIS
10.2.7. MILLIPORESIGMA (MERCK)
10.2.7.1. OVERVIEW
10.2.7.2. PRODUCT PORTFOLIO
10.2.7.3. SCOT ANALYSIS
10.2.7.4. STRATEGIC ANALYSIS
10.2.8. OHLY
10.2.8.1. OVERVIEW
10.2.8.2. PRODUCT PORTFOLIO
10.2.8.3. STRATEGIC INITIATIVES
10.2.8.4. SCOT ANALYSIS
10.2.8.5. STRATEGIC ANALYSIS
10.2.9. TATE & LYLE PLC
10.2.9.1. OVERVIEW
10.2.9.2. PRODUCT PORTFOLIO
10.2.9.3. STRATEGIC INITIATIVES
10.2.9.4. SCOT ANALYSIS
10.2.9.5. STRATEGIC ANALYSIS
10.2.10. SUPER BETA GLUCAN
10.2.10.1. OVERVIEW
10.2.10.2. PRODUCT PORTFOLIO
10.2.10.3. SCOT ANALYSIS
10.2.10.4. STRATEGIC ANALYSIS
10.2.11. KONINKLIJKE DSM N.V.
10.2.11.1. OVERVIEW
10.2.11.2. PRODUCT PORTFOLIO
10.2.11.3. SCOT ANALYSIS
10.2.11.4. STRATEGIC ANALYSIS
10.2.12. FRUTAROM
10.2.12.1. OVERVIEW
10.2.12.2. PRODUCT PORTFOLIO
10.2.12.3. SCOT ANALYSIS
10.2.12.4. STRATEGIC ANALYSIS
10.2.13. KERRY GROUP PLC
10.2.13.1. OVERVIEW
10.2.13.2. PRODUCT PORTFOLIO
10.2.13.3. STRATEGIC ANALYSIS
10.2.13.4. SCOT ANALYSIS
10.2.13.5. STRATEGIC ANALYSIS
10.2.14. LESAFFRE HUMAN CARE
10.2.14.1. OVERVIEW
10.2.14.2. PRODUCT PORTFOLIO
10.2.14.3. SCOT ANALYSIS
10.2.14.4. STRATEGIC ANALYSIS
10.2.15. PHARMACON ASA
10.2.15.1. OVERVIEW
10.2.15.2. PRODUCT PORTFOLIO
10.2.15.3. STRATEGIC INITIATIVES
10.2.15.4. SCOT ANALYSIS
10.2.15.5. STRATEGIC ANALYSIS

LIST OF TABLES
TABLE 1 NORTH AMERICA BETA GLUCAN MARKET BY COUNTRY 2018-2026 ($ MILLION)
TABLE 2 APPLICATIONS OF DIFFERENT BETA GLUCAN IN FOOD PRODUCTION
TABLE 3 NORTH AMERICA BETA GLUCAN MARKET BY SOURCE 2018-2026 ($ MILLION)
TABLE 4 NORTH AMERICA BETA GLUCAN MARKET BY END-USERS 2018-2026 ($ MILLION)
TABLE 5 NORTH AMERICA BETA GLUCAN MARKET BY CATEGORY 2018-2026 ($ MILLION)
TABLE 6 INVESTMENTS IN BETA GLUCAN
TABLE 7 NORTH AMERICA BETA GLUCAN MARKET BY COUNTRY ($ MILLION)

LIST OF FIGURES
FIGURE 1 NORTH AMERICA BETA GLUCAN MARKET BY SOURCE 2018-2026 ($ MILLION)
FIGURE 2 UNITED STATES BETA GLUCAN MARKET 2018-2026 ($ MILLION)
FIGURE 3 NORTH AMERICA SOLUBLE BETA GLUCAN MARKET 2018-2026 ($ MILLION)
FIGURE 4 NORTH AMERICA CEREALS MARKET 2018-2026 ($ MILLION)
FIGURE 5 EVOLUTION OF BETA-GLUCAN MARKET
FIGURE 6 GROWING HEALTHCARE EXPENDITURE IN UNITED STATES ($ PER CAPITA)
FIGURE 7 HEALTHCARE SPENDING PER CAPITA IN 2015 AND 2016
FIGURE 8 FUNCTIONAL FOOD AND BEVERAGES SALES IN BRAZIL 2009-2015 ($ BILLION)
FIGURE 9 COMMODITY PRICE INDEX OF WHEAT CROPS
FIGURE 10 NORTH AMERICA COSMETICS PRODUCTS MARKET 2015 ($ BILLION)
FIGURE 11 NORTH AMERICA BACTERIA MARKET 2018-2026 ($ MILLION)
FIGURE 12 NORTH AMERICA FUNGUS MARKET 2018-2026 ($ MILLION)
FIGURE 13 NORTH AMERICA YEAST MARKET 2018-2026 ($ MILLION)
FIGURE 14 NORTH AMERICA CEREAL MARKET 2018-2026 ($ MILLION)
FIGURE 15 NORTH AMERICA ALGAE MARKET 2018-2026 ($ MILLION)
FIGURE 16 NORTH AMERICA FOOD AND BEVERAGES MARKET 2018-2026 ($ MILLION)
FIGURE 17 NORTH AMERICA PERSONAL CARE MARKET 2018-2026 ($ MILLION)
FIGURE 18 NORTH AMERICA PHARMACEUTICALS MARKET 2018-2026 ($ MILLION)
FIGURE 19 NORTH AMERICA ANIMAL FEED MARKET 2018-2026 ($ MILLION)
FIGURE 20 NORTH AMERICA INSOLUBLE BETA GLUCAN MARKET 2018-2026 ($ MILLION)
FIGURE 21 NORTH AMERICA SOLUBLE BETA GLUCAN MARKET 2018-2026 ($ MILLION)
FIGURE 22 TOP 10 COUNTRIES WITH NUMBER OF PEOPLE LIVING WITH DIABETES IN MILLION (2015)
FIGURE 23 PERCENTAGE INCREMENT OF DIABETES ACROSS REGIONS (2015 TO 2040)
FIGURE 24 INVESTMENT PROPOSITION FOR NORTH AMERICA BETA GLUCAN MARKET BY END-USERS – 2017
FIGURE 25 UNITED STATES BETA GLUCAN MARKET 2018-2026
FIGURE 26 CANADA BETA GLUCAN MARKET 2018-2026
FIGURE 27 MARKET SHARE ANALYSIS OF TOP COMPANIES IN NORTH AMERICA BETA GLUCAN MARKET – 2017 (%)



【レポートのキーワード】

ベータグルカン

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ベータグルカンの北米市場(NORTH AMERICA BETA GLUCAN MARKET FORECAST 2018-2026 )]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆